Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FDMT compared with PCVX: revenue, margins and what each company keeps, and the suppliers and customers both name
FDMT
4D Molecular Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PCVX
Vaxcyte, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
FDMT
4D Molecular Therapeutics, Inc.
vs
PCVX
Vaxcyte, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
FDMT, solid
PCVX, dashed
FDMT
4D Molecular Therapeutics, Inc.
Change
11.99
▲
+5.45%
Mkt cap
$820.7M
Revenue
$4M
Q2 FY26
PCVX
Vaxcyte, Inc.
Change
60.52
▼
−0.17%
Regular session
Nov 3 '26
Mkt cap
$9.0B
Revenue
—
vs
Compare
Regular session
Nov 3 '26
FDMT
4D Molecular Therapeutics, Inc.
vs
PCVX
Vaxcyte, Inc.
11.99
▲
+5.45%
Price
60.52
▼
−0.17%
$820.7M
Mkt cap
$9.0B
Q2 FY26
$4M
Revenue
—
Change
Change
FDMT
11.99
▲
+5.45%
vs
PCVX
60.52
▼
−0.17%
Regular session
Nov 3 '26